z-logo
open-access-imgOpen Access
Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers
Author(s) -
YanMing Xu
Publication year - 1998
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.280.8.719
Subject(s) - lysophosphatidic acid , medicine , ovarian cancer , biomarker , gynecologic oncology , cancer , breast cancer , oncology , gastroenterology , stage (stratigraphy) , autotaxin , gynecologic cancer , gynecology , receptor , paleontology , biochemistry , chemistry , biology
Lysophosphatidic acid (LPA) has been shown to stimulate proliferation of ovarian cancer cells and is present in the ascitic fluid of patients with ovarian cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom